SAN DIEGO, May 9, 2019 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet pa… […]
New investors further fuel community-owned genomic and health data platform
SAN DIEGO, May 8, 2019 /PRNewswire/ — LunaPBC, founder of LunaDNA, the first community-owned genomic and health data platform, today announced the close of $4.6 million in n… […]
Enables Expanded Access to the Company’s Portfolio of Tests
SAN DIEGO, April 23, 2019 /PRNewswire/ — Epic Sciences, Inc. announced today that it has received a CE mark for its Liquid Biopsy Test Collection Kit, allowing for sale and distribution of… […]
BioMed Realty also closes a $430 million financing on the first phase of Gateway of Pacific after executing a long-term lease with AbbVie Inc. for 480,000 square feet
SAN DIEGO, March 20, 2019 /PRNewswire/ — BioMed Realty, a Blackstone portfolio co… […]
LA IVF adds fourth location in Southern California, bringing successful, customized fertility treatments to local and international patients
LOS ANGELES, March 18, 2019 /PRNewswire/ — LA IVF Clinic (LAIVF) opened doors to its fourth clinic in March,… […]
SAN DIEGO, March 12, 2019 /PRNewswire/ — Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company, using a precision medicine approach to develop drugs that target cell division (mitosis) for the treatment of leukemias, lymph… […]
$55 million equity financing from Athyrium and Secura Bio Executive Team$90 million debt financing with $50 million initial tranche funded immediately and additional $40 million of funding available
HENDERSON, Nev. and SAN DIEGO, March 5, 2019 /PRNew… […]
Funds will go toward recruiting top researchers and improving facilities in the South Bay region of LA County – one of the nation’s top ten biotech clusters
LOS ANGELES, Feb. 11, 2019 /PRNewswire/ — Southern California philanthropists Melanie and Ri… […]
Qualigen continues to strengthen its cancer drug technology portfolio
CARLSBAD, Calif., Dec. 18, 2018 /PRNewswire/ — Qualigen, Inc., and Advanced Cancer Therapeutics, LLC (ACT) today announced that Qualigen has licensed certain ACT patents, intellec… […]
SAN DIEGO and FREISING, Germany, Dec. 18, 2018 /PRNewswire/ — Ajinomoto Bio-Pharma Services, a fully owned subsidiary of Ajinomoto Co. Inc. (TSE: 2802), and XL-protein GmbH, a privately owned German biopharmaceutical company, are pleased to announ… […]
Copyright © 2019 San Diego Biotechnology Network (DBA of Comprendia. LLC)
